Elliott Entry at Glaxo Piles Pressure on CEO to Speed Turnaround
Elliott Management Corp.’s decision to build a stake in GlaxoSmithKline Plc piles more pressure on Chief Executive Officer Emma Walmsley to speed up a turnaround of the U.K. pharmaceutical giant.